These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 29878063)
1. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence. Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063 [TBL] [Abstract][Full Text] [Related]
5. Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease. Hoffmann MM Curr Cardiol Rep; 2018 May; 20(7):56. PubMed ID: 29802474 [TBL] [Abstract][Full Text] [Related]
7. Muscle and statins: from toxicity to the nocebo effect. Pedro-Botet J; Climent E; Benaiges D Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941 [TBL] [Abstract][Full Text] [Related]
9. Statin myotoxicity: a review of genetic susceptibility factors. Needham M; Mastaglia FL Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465 [TBL] [Abstract][Full Text] [Related]
10. Approach to clinical and genetic characterization of statin-induced myopathy. Feng Q Methods Mol Biol; 2014; 1175():67-90. PubMed ID: 25150867 [TBL] [Abstract][Full Text] [Related]
11. Treatment Options for Statin-Associated Muscle Symptoms. Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138 [TBL] [Abstract][Full Text] [Related]
12. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis. Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148 [TBL] [Abstract][Full Text] [Related]
13. An overview of statin-induced myopathy and perspectives for the future. Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708 [No Abstract] [Full Text] [Related]
14. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118 [TBL] [Abstract][Full Text] [Related]
15. Statin-Associated Muscle Disease: Advances in Diagnosis and Management. Taylor BA; Thompson PD Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222 [TBL] [Abstract][Full Text] [Related]
16. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population. Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754 [TBL] [Abstract][Full Text] [Related]